Sentiment-Signal
19,4
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Unternehmen & Branche
| Name | Benitec Biopharma Inc. |
|---|---|
| Ticker | BNTC |
| CIK | 0001808898 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 319,7 Mio. USD |
| Beta | 0,12 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | 0 | -11,837,000 | -0.26 | 190,681,000 | 187,361,000 |
| 2025-09-30 | 10-Q | 0 | -8,965,000 | -0.22 | 96,027,000 | 93,599,000 |
| 2025-06-30 | 10-K | -37,917,000 | -1.05 | 99,592,000 | 97,295,000 | |
| 2025-03-31 | 10-Q | 0 | -9,354,000 | -0.24 | 105,209,000 | 97,570,000 |
| 2024-12-31 | 10-Q | 0 | -9,552,000 | -0.26 | 79,068,000 | 75,941,000 |
| 2024-09-30 | 10-Q | 0 | -5,059,000 | -0.18 | 68,774,000 | 64,180,000 |
| 2024-09-30 | 10-K | -5,059,000 | -0.18 | |||
| 2024-06-30 | 10-K | -21,751,000 | -1.22 | 52,210,000 | 47,248,000 | |
| 2024-03-31 | 10-Q | 0 | -4,279,000 | -0.23 | 14,999,000 | 11,500,000 |
| 2023-12-31 | 10-Q | 0 | -6,798,000 | -2.64 | 21,353,000 | 15,470,000 |
| 2023-09-30 | 10-Q | 0 | -5,954,000 | -3.05 | 27,053,000 | 22,308,000 |
| 2023-06-30 | 10-K | -19,562,000 | -14.12 | 4,464,000 | 202,000 | |
| 2023-03-31 | 10-Q | 54,000 | -4,397,000 | -2.67 | 8,220,000 | 4,713,000 |
| 2022-12-31 | 10-Q | 14,000 | -5,411,000 | -3.34 | 11,905,000 | 8,994,000 |
| 2022-09-30 | 10-Q | 0 | -5,093,000 | -7.98 | 18,115,000 | 14,613,000 |
| 2022-06-30 | 10-K | -18,208,000 | -37.88 | 5,973,000 | 2,882,000 | |
| 2022-03-31 | 10-Q | 48,000 | -3,275,000 | -0.40 | 10,064,000 | 7,520,000 |
| 2021-12-31 | 10-Q | 25,000 | -4,821,000 | -0.59 | 14,014,000 | 10,836,000 |
| 2021-09-30 | 10-Q | 0 | -5,045,000 | -0.62 | 17,836,000 | 15,475,000 |
| 2021-06-30 | 10-K | 59,000 | -13,882,000 | -3.23 | 21,379,000 | 20,010,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.